Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert.

Slides:



Advertisements
Similar presentations
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to June 2002 Robert S. Remis, Carol Swantee, Carol Major,
Advertisements

Sexually transmitted infections: epidemiological evidence of need Dr Kirsty Foster Consultant in Health Protection Public Health England Centre, North.
Satellite meeting on the STARHS HIV diagnostic assay in association with the 15th International AIDS Conference July 2004, Bangkok, Thailand Robert S.
Case Identification for the Missouri Perinatal Hepatitis B Prevention Program Libby Landrum, RN, MSN Viral Hepatitis Prevention Manager Bureau HIV, STD,
HIV and STD in Maine Data from the Bureau of Health HIV/STD Program Contact: Mark Griswold (207)
Pertussis Disease Pertussis (‘whooping cough’) is a bacterial infection affecting the respiratory system, caused by the organism Bordetella pertussis.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
THE CORE STUDY COMPARING TWO STRATEGIES FOR ENROLLING HIV-INFECTED PREGNANT WOMEN FROM ANTENATAL CARE TO CARE AND TREATMENT SERVICES IN CAMEROON: CONTINUUM.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.
00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.
Module 1: Final Case Study #1-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 1-CS-2.
1 Towards getting more HIV- positive infants on lifesaving treatment: assessing turn- around times for early infant diagnosis in Lesotho M Gill, HJ Hoffman,
1Management Sciences for Health Stronger health systems. Greater health impact. More HIV positive infants and mothers identified through HIV testing in.
Induced Abortion: Incidence and Trends Worldwide 1995 to 2008 Presented by Gilda Sedgh Guttmacher Institute January 18, 2012.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
Feedback from Pregnancy research group UK CHIC / UK HIV Drug Resistance Database Meeting, 2 July 2010 Pregnancy Group: Jane Anderson, Loveleen Bansi, Susie.
HIV Rapid Testing Dr. Kevin Harvey National HIV/AIDS Programme Ministry of Health Jamaica.
Perinatal HIV Testing in Utah Lois Blobaum, BSN, Theresa Garrett, MSN and Nan Streeter, RN, MS Utah Department of Health.
Healthy Kansans living in safe and sustainable environments.
HIV infection among men who have sex with men in Ontario: Analysis by race/ethnicity Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring.
Africans and HIV in the UK: an epidemiological perspective Nov 2006 Tim Chadborn On behalf of the HIV Reporting Section with special thanks to Julia Abernethy.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Click to edit Master title style Research Objective: The CDC estimates that 1 in 4 people living with HIV in the U.S. are unaware of their HIV status.
Epidemiology of Hepatitis C Infection in Canada Robert S. Remis MD, MPH, FRCPC Department of Public Health Sciences University of Toronto 1st Canadian.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand.
TESTING FOR HIV TO PREVENT MOTHER-INFANT TRANSMISSION POLICY CONSIDERATIONS ROBERT S. REMIS MD DEPARTMENT OF PUBLIC HEALTH SCIENCES, UNIVERSITY OF TORONTO.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.
Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.
ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES XVIII International AIDS Conference, July , Vienna Austria Recent Trends in estimated HIV-1.
eHARS to CAREWare Pilot Project Update and Training
Progress toward COP 12 targets Mozambique-ICB October
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Bias in estimates of HIV incidence based on the detuned assay: A proposed solution Robert S Remis, Robert WH Palmer, Janet M Raboud Department of Public.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
Using the detuned assay to determine HIV incidence in Ontario: Results and methodologic perspectives Robert S. Remis, Carol Major, Carol Swantee, Margaret.
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
Trends in HIV incidence in Ontario based on the detuned assay: Update to October 2000 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Evelyn.
The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
HIV Testing and Diagnosis of Emergency Department Patients New Jersey, Charlotte Sadashige, MSS * ; Sindy Paul, MD, MPH * ; Eugene Martin, PhD.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
July 2015 Core Epidemiology Slides.
Laboratory Enhancement Study: Using the detuned assay to determine HIV incidence in Ontario October 1999 – July 2000 Robert S. Remis, Carol Major, Carol.
The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,
Marked increase in first-time HIV diagnoses in Ontario, 2002.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand.
HIV and AIDS Data Hub for Asia-Pacific 1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
Notified AIDS and HIV Infection Cases in the Seychelles: Epidemiological Trends Ministry of Health, SeychellesMinistry of Health, Seychelles –N. E. Udonwa.
Abstract #TUPDE202: Collaboration and Cross Training between Health and Correctional Services Leads to More Integrated Services for PHAs in Prison: Poster.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to December 2000 Robert S. Remis, Carol Major, Margaret.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Global summary of the AIDS epidemic, December 2007
The impact of ethnicity on presentation to antenatal care among pregnant women living with HIV in the UK and Ireland.
The Indigenous HIV/AIDS Epidemic: Are We Invisible?
HIV Diagnosis and the Cascade of Care in Ontario
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
Epidemiologic Update on the HIV Epidemic in Ontario
Health Protection Surveillance Centre
Presentation transcript:

Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert W.H. Palmer, Mark Fisher, Keyi Wu, Susan King, Peggy Millson, Liviana Calzavara, Elaine Whittingham and Carol Major Department of Public Health Sciences, University of Toronto Laboratories Branch, Ontario Ministry of Health and Long-Term Care Hospital for Sick Children 15th International Conference on AIDS Bangkok, Thailand, July 11-16, 2004

Background 1991: HIV prevalence 0.23/1,000 in childbearing women 1991: HIV prevalence 0.23/1,000 in childbearing women 1994: ZDV found to reduce HIV transmission 1994: ZDV found to reduce HIV transmission 1997: Modeled HIV prevalence 0.70/1,000 and % of pregnant women tested for HIV 1997: Modeled HIV prevalence 0.70/1,000 and % of pregnant women tested for HIV

Ontario HIV screening program 1995: Advisory to physicians to consider HIV test for pregnant women at increased risk 1995: Advisory to physicians to consider HIV test for pregnant women at increased risk December 1998: Program to offer HIV testing to all pregnant women December 1998: Program to offer HIV testing to all pregnant women Sep Jan 2002: Memo sent with test report to physicians when HIV test prescribed Sep Jan 2002: Memo sent with test report to physicians when HIV test prescribed Sep 2003: Memo reinstated with refinements Sep 2003: Memo reinstated with refinements

Study objectives Quantify and characterize HIV prevalence among women of childbearing age in Ontario Quantify and characterize HIV prevalence among women of childbearing age in Ontario Evaluate the Ontario HIV screening program Evaluate the Ontario HIV screening program

Data management Data extracted from LAByrinth Data extracted from LAByrinth Prenatal testing records linked to HIV diagnostic database Prenatal testing records linked to HIV diagnostic database Matching allowed for different spelling and structure of Matching allowed for different spelling and structure of name and reversal of month-day in birthdate Tests aggregated into episode equivalent to gestation period and HIV test uptake analysed for pregnancies Tests aggregated into episode equivalent to gestation period and HIV test uptake analysed for pregnancies

Unlinked seroprevalence study For 2002, specimens from women not HIV tested were tested after personal identifiers removed (anonymous, unlinked study) For 2002, specimens from women not HIV tested were tested after personal identifiers removed (anonymous, unlinked study) Data on age group and health region of test retained Data on age group and health region of test retained HIV prevalence examined and compared to that among women tested HIV prevalence examined and compared to that among women tested

Proportion of pregnancies tested for HIV by health region, 1st quarter %38,70843,881Total 87% 88% 90% 87% 92% 90% 89% 91% 10,186 9,191 4,625 6,129 3,220 2,970 2, ,741 10,427 5,162 7,055 3,504 3,310 2, Toronto Central East, other Southwest Central West Ottawa Eastern, other Northern N/A or OFP Proportion tested HIV tested Number of preg’s

HIV testing among pregnancies by timing of HIV test, Ontario, Jan 1999-Mar 2004 Proportion of pregnancies (%)

HIV testing among pregnancies for selected health regions, Jan 1999-Mar 2004

Number of PHU’s in each region by proportion tested for HIV, 1st quarter % % %70- 79%60- 69% Total 8 4 3Northern Eastern other 1 1 Ottawa 725Central West Southwest 6 5 Central East other 1 Toronto Total PHU’s Number of PHU’s by proportion of HIV testing uptake 1 1

Number of HIV-positive pregnancies Prior Current Total TOTAL

HIV-positive and number of pregnancies by test status, anonymous unlinked study 2002

Interpretation Based on recent analysis, actual uptake of HIV testing was slightly greater than our results suggest due to non-matches (for anonymous and coded HIV testing) Based on recent analysis, actual uptake of HIV testing was slightly greater than our results suggest due to non-matches (for anonymous and coded HIV testing) Estimated difference is 2% Estimated difference is 2% Study does not indicate why HIV test was not carried out Study does not indicate why HIV test was not carried out

Conclusions Critical to capture data from HIV diagnostic database in addition to prenatal database Critical to capture data from HIV diagnostic database in addition to prenatal database HIV testing increased from 40% to 50% from January to May 1999, with modest increase until September 2001 HIV testing increased from 40% to 50% from January to May 1999, with modest increase until September 2001 Impact of memo: from 60% to 75% Impact of memo: from 60% to 75% Uptake in latest quarter 90%, though slightly less (85%) for current pregnancy only Uptake in latest quarter 90%, though slightly less (85%) for current pregnancy only Less regional variation in HIV test uptake Less regional variation in HIV test uptake In five years, 201 women identified as HIV-positive, 51 previously diagnosed, 150 newly diagnosed In five years, 201 women identified as HIV-positive, 51 previously diagnosed, 150 newly diagnosed

Conclusions (continued) Based on results of 2002 unlinked seroprevalence study Based on results of 2002 unlinked seroprevalence study HIV prevalence higher (almost double) among women not tested HIV prevalence higher (almost double) among women not tested In 2002, though ~ 82% of pregnant women tested, only ~ 63% of HIV-infected pregnant women tested In 2002, though ~ 82% of pregnant women tested, only ~ 63% of HIV-infected pregnant women tested According to the preliminary results from a model (data not shown), about 6-8 mother-infant HIV transmissions occurred in 2003 According to the preliminary results from a model (data not shown), about 6-8 mother-infant HIV transmissions occurred in 2003

Acknowledgments Prenatal HIV Screening Evaluation Committee Prenatal HIV Screening Evaluation Committee Frank McGee, coordinator AIDS Bureau Frank McGee, coordinator AIDS Bureau Janis Tripp, consultant AIDS Bureau Janis Tripp, consultant AIDS Bureau Funding Funding AIDS Bureau, Ontario Ministry of Health and Long-Term Care AIDS Bureau, Ontario Ministry of Health and Long-Term Care Centre for Disease Prevention and Control, Health Protection, Health Canada Centre for Disease Prevention and Control, Health Protection, Health Canada